101 related articles for article (PubMed ID: 6183830)
1. Study of the immunopotentiator effects of dialyzable leukocyte extracts obtained out of leukocytes previously used for interferon production.
Arala-Chaves MP; Porto MT; Kauppinen HL; Massa AA; Myllylä G
Vox Sang; 1982 Nov; 43(5):233-42. PubMed ID: 6183830
[TBL] [Abstract][Full Text] [Related]
2. Batch-to-batch reproducibility of Transferon™.
Medina-Rivero E; Merchand-Reyes G; Pavón L; Vázquez-Leyva S; Pérez-Sánchez G; Salinas-Jazmín N; Estrada-Parra S; Velasco-Velázquez M; Pérez-Tapia SM
J Pharm Biomed Anal; 2014 Jan; 88():289-94. PubMed ID: 24099727
[TBL] [Abstract][Full Text] [Related]
3. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. 1. Antigen-dependent inhibition and antigen-independent inhibition and enhancement of migration.
Wilson GB; Fudenberg HH; Horsmanheimo M
J Lab Clin Med; 1979 May; 93(5):800-18. PubMed ID: 429876
[TBL] [Abstract][Full Text] [Related]
4. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay.
Borkowsky W; Suleski P; Bhardwaj N; Lawrence HS
J Immunol; 1981 Jan; 126(1):80-2. PubMed ID: 6161170
[TBL] [Abstract][Full Text] [Related]
5. An animal model for evaluation of antigen-specific dialyzable leukocyte extracts therapy of osteosarcoma.
Tsang KY; Pan JF; Fudenberg HH
Clin Immunol Immunopathol; 1987 Mar; 42(3):360-9. PubMed ID: 3470162
[TBL] [Abstract][Full Text] [Related]
6. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg].
Hashimoto Y; Sekiguchi S
Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264
[TBL] [Abstract][Full Text] [Related]
7. New and cost effective cell-based assay for Dialyzed Leukocyte Extract (DLE)-induced Jurkat cells proliferation under azathioprine treatment.
Cardoso FM; Tomkova M; Petrovajova D; Bubanova M; Ragac O; Hornakova T
J Pharm Biomed Anal; 2017 May; 138():100-108. PubMed ID: 28189890
[TBL] [Abstract][Full Text] [Related]
8. Dialyzable leukocyte extracts activate TLR-2 on monocytes.
García-Hernández U; Robledo-Avila FH; Alvarez-Jiménez VD; Rodríguez-Cortés O; Wong-Baeza I; Serafín-López J; Aguilar-Anguiano LM; Estrada-Parra S; Estrada-García I; Pérez-Tapia SM; Chacón-Salinas R
Nat Prod Commun; 2014 Jun; 9(6):853-6. PubMed ID: 25115098
[TBL] [Abstract][Full Text] [Related]
9. Dialyzable leukocyte extract differentially regulates the production of TNFalpha, IL-6, and IL-8 in bacterial component-activated leukocytes and endothelial cells.
Ojeda MO; van't Veer C; Fernández Ortega CB; Araña Rosainz Mde J; Buurman WA
Inflamm Res; 2005 Feb; 54(2):74-81. PubMed ID: 15750714
[TBL] [Abstract][Full Text] [Related]
10. Liposome-facilitated enhancement of in vitro immunity to human colon cancer.
Sengupta J; Klesius PH; Tom BH
Immunol Invest; 1985 Feb; 14(1):7-26. PubMed ID: 3997212
[TBL] [Abstract][Full Text] [Related]
11. Distinct components in dialyzable leukocyte extracts (DLE) have specific and nonspecific effects on cellular immunity as shown by leukocyte migration inhibition.
Wilson GB; Fudenberg HH; Bahm VJ
Trans Assoc Am Physicians; 1978; 91():295-332. PubMed ID: 754397
[No Abstract] [Full Text] [Related]
12. Stabilization of Salmonella-specific dialyzable leukocyte extracts.
Mikula I; Pistl J; Rosocha J
Vet Immunol Immunopathol; 1992 Apr; 32(1-2):103-21. PubMed ID: 1604793
[TBL] [Abstract][Full Text] [Related]
13. Tołpa Torf Preparation (TTP) induces interferon and tumor necrosis factor production in human peripheral blood leukocytes.
Inglot AD; Zielińska-Jenczylik J; Piasecki E
Arch Immunol Ther Exp (Warsz); 1993; 41(1):73-80. PubMed ID: 7694559
[TBL] [Abstract][Full Text] [Related]
14. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
Wilson GB; Paddock GV; Fudenberg HH
Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for immunotherapy of antigen-specific defects with transfer factor.
Wilson GB; Fudenberg HH; Keller RH
J Clin Lab Immunol; 1984 Feb; 13(2):51-8. PubMed ID: 6202873
[TBL] [Abstract][Full Text] [Related]
16. Transfer of cell-mediated immunity to Paracoccidioides brasiliensis in hamsters with dialysable leukocyte extracts.
Peraçoli MT; Montenegro MR; Soares AM; Mota NG
J Med Vet Mycol; 1990; 28(1):35-46. PubMed ID: 1694543
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity: correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract.
Mazaheri R; Hamblin AS; Zuckerman AJ
Cell Immunol; 1983 Nov; 82(1):147-62. PubMed ID: 6196129
[TBL] [Abstract][Full Text] [Related]
18. Mitigating effects of dialysable leukocyte extract (DLE) on the experimental allergic uveitis (EAU) of the rabbit.
Fricke HJ; Schröder KD; Metzner G; Schröder I; Haroske D; Tilgner S; Sych FJ; Klein S; Jäger L
Allergol Immunopathol (Madr); 1990; 18(5):269-75. PubMed ID: 2097893
[TBL] [Abstract][Full Text] [Related]
19. [Dialyzed leukocyte extracts for the treatment of recurrent and severe infections in pediatric patients with cellular immunodeficiency: 15 years of experience].
Ayala MC; González NM; Palacios G; Rivera-Morales LG; Rodríguez-Padilla C
Rev Alerg Mex; 2019; 66(1):27-37. PubMed ID: 31013404
[TBL] [Abstract][Full Text] [Related]
20. Transfer of osteosarcoma-specific cell-mediated immunity in hamsters by rabbit dialyzable leukocyte extracts.
Tsang KY; Fudenberg HH; Pan JF
Cell Immunol; 1985 Feb; 90(2):295-302. PubMed ID: 3855389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
